Skip Navigation


Cardiovascular Research Advance Access first published online on May 29, 2008
This version [Corrected Proof] published online on June 23, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn137
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
79/4/562    most recent
cvn137v2
cvn137v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thum, T.
Right arrow Articles by Bauersachs, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thum, T.
Right arrow Articles by Bauersachs, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

MicroRNAs: novel regulators in cardiac development and disease

Thomas Thum1,2,*,{dagger}, Daniele Catalucci3,{dagger} and Johann Bauersachs1,*

1 Medizinische Klinik und Poliklinik I, Universitätsklinikum, Julius-Maximilians-Universität, Josef-Schneider-Street 2, D-97080 Würzburg, Germany
2 Nachwuchsgruppe Cardiac Wounding and Healing, Interdisziplinäres Zentrum für Klinische Forschung (IZKF), Universitätsklinikum, Julius-Maximilians-Universität, Würzburg, Germany
3 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Multimedica, Milan 20138, Italy

* Corresponding authors. Tel: +49 931 201 36455; fax: +49 931 201 36664. E-mail address: Thum_T{at}klinik.uni-wuerzburg.de or Bauersachs_J{at}medizin.uni_wuerzburg.de

MicroRNAs (miRNAs) are endogenous, small ribonucleotides regulating the translation of target messenger RNAs that have been shown to be involved in orchestrating growth, development, function, and stress responses of various organs, including the heart. Muscle miRNAs are mainly controlled by a network of myogenic transcription factors, and throughout cardiac development they fine-tune regulatory protein levels in a spatiotemporal manner. Recent profiling studies revealed that miRNA expression patterns are derailed in both human cardiac disease and animal models of cardiac hypertrophy and failure. Modulation of miRNA expression in vitro as well as in vivo has revealed an important role of miRNAs in regulating heart function, particularly cardiac growth and conductance. Here, we overview the recent findings on miRNAs in cardiac development and disease and report the latest advances in the identification and validation of miRNA targets, which are important for a comprehensive understanding of cardiac miRNA function. Finally, we focus on the development and use of miRNA antagonists (antagomirs) to target miRNAs in vivo, which may translate into novel therapeutic strategies for heart disease in the future.

KEYWORDS MicroRNAs; Heart failure; Cardiac hypertrophy; Dicer; Antagomirs

Time for primary review: 28 days

{dagger} Both the authors contributed equally.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
S. Greco, M. De Simone, C. Colussi, G. Zaccagnini, P. Fasanaro, M. Pescatori, R. Cardani, R. Perbellini, E. Isaia, P. Sale, et al.
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia
FASEB J, October 1, 2009; 23(10): 3335 - 3346.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. R. Sipido, A. Tedgui, S. D. Kristensen, G. Pasterkamp, H. Schunkert, M. Wehling, P. G. Steg, W. Eisert, F. Rademakers, B. Casadei, et al.
Identifying needs and opportunities for advancing translational research in cardiovascular disease
Cardiovasc Res, August 1, 2009; 83(3): 425 - 435.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Goette
Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?
Cardiovasc Res, August 1, 2009; 83(3): 421 - 422.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
X. Liu, Y. Cheng, S. Zhang, Y. Lin, J. Yang, and C. Zhang
A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
Circ. Res., February 27, 2009; 104(4): 476 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
E. van Rooij and E. N. Olson
Searching for MiR-acles in Cardiac Fibrosis
Circ. Res., January 30, 2009; 104(2): 138 - 140.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
E. van Rooij, W. S. Marshall, and E. N. Olson
Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense
Circ. Res., October 24, 2008; 103(9): 919 - 928.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Thum
Cardiac Dissonance Without Conductors: How Dicer Depletion Provokes Chaos in the Heart
Circulation, October 7, 2008; 118(15): 1524 - 1527.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. Condorelli and S. Dimmeler
MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis
Cardiovasc Res, September 1, 2008; 79(4): 551 - 552.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.